Brand's highest-revenue ASIN was suppressed after a routine Amazon claims review flagged language in the bullets that had been live for 14 months without issue. The audit revealed the same vulnerability in three additional ASINs — all fixed before Amazon noticed.
This case file is about what we found during an emergency audit triggered by a listing suppression — and more importantly, what we found that the brand didn’t know to ask about.
The brand contacted us on a Monday morning. Their hero ASIN — the product responsible for roughly 40% of their Amazon revenue — had been suppressed the previous Friday afternoon. By the time they realized it, the product had been unavailable for nearly three days. PPC spend had continued running against a suppressed listing for most of that window.
They wanted the ASIN back. That was the request. What they got was more than that.
The suppression itself was straightforward to reverse. The bullet copy contained structure/function language that Amazon had reclassified as a drug claim in a policy update three months earlier. The brand’s agency — a generalist PPC shop — hadn’t flagged the change. The listing had been live for 14 months before the reclassification caught up with it.
The harder finding was that three other ASINs in the catalog had similar language patterns. Not identical — but close enough that the same automated review that flagged the hero ASIN would likely catch them next. Two of those three were in the top five revenue ASINs. Left unaddressed, this was a second and third suppression waiting to happen.
We also found a structural issue that went deeper than the copy itself. The brand had no claims-language review protocol. Listings were updated individually — new A+ content for one product, bullet tweaks for another, new supplement facts panel for a third — without anyone reviewing whether claims language was consistent and compliant across the full catalog. This is how the same vulnerability ends up in multiple listings. One agency staffer writes bullets for ASIN A, another writes bullets for ASIN B, the language patterns drift, and nobody owns the category-level claims review.
Three things, in sequence.
First, we fixed the suppressed ASIN. New bullet copy, resubmitted with documentation, restored in 6 business days. That part was execution — not easy, but not unusual for a brand with clean compliance history.
Second, we rewrote the three vulnerable ASINs proactively before Amazon’s next review cycle. This is the work most agencies don’t do because it doesn’t show up in a monthly report. There’s no revenue event to point to. Just four listings that didn’t get suppressed because we caught the pattern.
Third, we built a category-wide claims review into the ongoing engagement. Every listing gets reviewed against Amazon’s current supplement policy quarterly, with policy-change monitoring catching updates in between. This is what Verid8 does for all our clients — but this brand is a good example of what happens without it.
The ASIN was back. Revenue resumed the following week. PPC was immediately rescoped so it couldn’t run against suppressed listings in the future.
More importantly, the brand now understands that compliance isn’t a problem you fix once. It’s an ongoing category of work that needs continuous attention — and the cost of not doing it isn’t just the occasional suppression. It’s the fact that most brands only find out their compliance posture is weak when Amazon tells them.
Anonymized case files are how we show what we actually find on audits, without exposing the brands we work with. If you run a supplement brand on Amazon US and any of the findings above sound familiar — claims language written 12+ months ago, inconsistent language patterns across ASINs, no quarterly compliance review — you probably have the same vulnerabilities. The only question is whether you find them before Amazon does.
Every audit surfaces findings this specific. The only question is what's hiding in your account.